Reports
The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.
PRIORITY PRESS - 74th Annual Meeting of the American College of Rheumatology and the 45th Annual Meeting of the Association of Rheumatology Health Professionals
Evolving Management of Extra-articular Rheumatic Disease
Atlanta, Georgia / November 7-11, 2010
Atlanta - It is estimated that 30% of patients with psoriasis also have psoriatic arthritis (PsA), a potential cause for irreversible joint damage. Many tools have been developed in order to identify active PsA earlier among individuals...
MEDICAL FRONTIERS - 74th Annual Meeting of the American College of Rheumatology
Selective B-cell-Targeted Therapy in Rheumatoid Arthritis and Other Autoimmune Diseases
Atlanta, Georgia / November 7-11, 2010
Atlanta - Treatment of rheumatoid arthritis (RA) with biologics has led to a fundamental shift in therapy. While tumour necrosis factor (TNF) inhibitors are used as first-line biologics, 30% of patients treated do not sufficiently respond...
PRIORITY PRESS - 32nd Annual Meeting of the American Society for Bone and Mineral Research (ASBMR)
Preserving Bone and Muscle Health
Toronto, Ontario / October 15-19, 2010
TO EARN CME CREDITS, PLEASE SEE BELOW Toronto - With our aging population, the incidence of age-related diseases, including osteoporosis (OP), is increasing. Age-related muscle loss is also common and strategies aimed at preventing falls...
PHYSICIAN PERSPECTIVE - Viewpoint Based on presentations from 32nd Annual Meeting of the American Society for Bone and Mineral Research (ASBMR)
Highlights from ASBMR 2010
Toronto, Ontario / October 15-19, 2010
INTRODUCTION With the aging populations in Western countries, the frequency of diseases associated with aging, including osteoporosis (OP), will become an increasing burden. Age-related bone and muscle loss are common and therefore...
PRIORITY PRESS - 2010 Annual European Congress of Rheumatology (EULAR)
Targeted Cytokine Blocker Efficacy in Rheumatoid Arthritis Trials
Rome, Italy / June 16-19, 2010
Rome - The rapid expansion of biological drug classes that downregulate the inflammatory response is substantially broadening the therapeutic options in rheumatoid arthritis (RA). Following a proliferation of tumour necrosis factor (TNF)...
PHYSICIAN PERSPECTIVE - Viewpoint based on presentations from the First Systemic Sclerosis World Congress
Focus on Systemic Sclerosis Patients For Early Diagnosis and Treatment of Pulmonary Arterial Hypertension
Florence, Italy / February 11-13, 2010
INTRODUCTION Systemic sclerosis (SSc) is a multi-system connective tissue disease characterized by excessive fibrosis, inflammation and vasculopathy; it affects both the skin and internal organs. A devastating complication of SSc is...
PRIORITY PRESS - 73rd Annual Meeting of the American College of Rheumatology
New Diagnostic and Severity Criteria Broaden Spectrum of Fibromyalgia Management
Philadelphia, Pennsylvania / October 17-21, 2009
Philadelphia - Fibromyalgia (FM) is a chronic, debilitating condition characterized by pain, fatigue, functional impairment and sleep disturbances. Until now, physicians have had only one set of criteria by which to diagnose the disorder,...
PRIORITY PRESS - 73rd Annual Meeting of the American College of Rheumatology
Vasoprotection in Systemic Sclerosis: New Strategies for Raynaud’s Phenomenon
Philadelphia, Pennsylvania / October 17-21, 2009
Philadelphia - Systemic sclerosis presents a vascular phenotype and Raynaud’s phenomenon (RP) is its most common initial symptom. Strategies aimed at protecting the vasculature from vasospasm and vasculopathy have the potential to modify...
ABSTRACTS IN PERSPECTIVE - based on presentations from the 73rd Annual Meeting of the American College of Rheumatology
Treatment Effects and Considerations for IL-6 Inhibition in Rheumatoid Arthritis
Philadelphia, Pennsylvania / October 17-21, 2009
EDITORIAL OVERVIEW: Majed Khraishi, MB, BCh, FRCPC Medical Director (Rheumatology), Nexus Clinical Research, Clinical Professor of Medicine (Rheumatology), Memorial University of Newfoundland, St. John’s, Newfoundland Disease-modifying...